NPI: 1891763132 · TALLAHASSEE, FL 32301 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,060 | $2.74M |
| 2019 | 16,447 | $2.88M |
| 2020 | 20,170 | $3.22M |
| 2021 | 11,841 | $1.39M |
| 2022 | 7,349 | $1.21M |
| 2023 | 5,545 | $303K |
| 2024 | 2,627 | $150K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,196 | 1,293 | $4.04M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,167 | 1,875 | $3.42M |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,307 | 1,145 | $2.11M |
| A4657 | Syringe, with or without needle, each | 3,638 | 1,241 | $920K |
| J1756 | Injection, iron sucrose, 1 mg | 4,383 | 904 | $580K |
| 83970 | 1,108 | 544 | $171K | |
| 85041 | 913 | 605 | $144K | |
| 85048 | 914 | 605 | $144K | |
| 83540 | 593 | 386 | $87K | |
| 83550 | 591 | 384 | $87K | |
| 82728 | 584 | 380 | $86K | |
| 82108 | 212 | 144 | $35K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 182 | 91 | $29K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 140 | 74 | $25K |
| 90674 | 14 | 14 | $6K | |
| G0008 | Administration of influenza virus vaccine | 16 | 16 | $4K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 81 | 37 | $0.00 |